OrthoPediatrics Corp.
Last updated September 27, 2026
Organization details
- Legal name
- OrthoPediatrics Corp.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- KIDS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001425450
Board of directors
-
(Reynolds) Marie C. Infante · DirectorSince 2023
-
Bryan W. Hughes · DirectorSince 2023
-
David R. Bailey · Director · President and CEOSince 2023
-
David R. Pelizzon · DirectorSince 2023
-
Fred Hite · Director · COO and CFOSince 2023
-
George Sinclair Mitchell Dyer · DirectorSince 2023
-
Harold Ruf · DirectorSince 2023
-
Jimmy Duane McDonald · DirectorSince 2023
-
Kelly Laine Fischer · DirectorSince 2025
-
Mark C. Throdahl · DirectorSince 2023
-
Samuel D. Riccitelli · DirectorSince 2023
-
Terry D. Schlotterback · DirectorSince 2023
Chief executives
David R. Bailey
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via David R. Pelizzon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,003,450
- 5 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | David R. Pelizzon Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | Bryan W. Hughes Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | Kelly Laine Fischer Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | Samuel D. Riccitelli Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | Harold Ruf Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | David R. Bailey Director, Officer (President and CEO) | Grant or award | +119,140 | — | — |
| Jun 9, 2026 | Jimmy Duane McDonald Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | (Reynolds) Marie C. Infante Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | Mark C. Throdahl Director | Grant or award | +11,436 | — | — |
| Jun 9, 2026 | George Sinclair Mitchell Dyer Director | Grant or award | +11,436 | — | — |
| May 13, 2026 | Gerritzen Daniel J Officer (General Counsel and Secretary) | Gift | −2,479 | — | — |
| Mar 16, 2026 | David R. Bailey Director, Officer (President and CEO) | Open-market sale | −19,535 | $17.25 | $336,979 |
| Mar 16, 2026 | Hauser Joseph W Officer (Pres. Trauma & Def. Correction) | Open-market sale | −8,596 | $17.25 | $148,281 |
| Mar 16, 2026 | Fred Hite Director, Officer (COO and CFO) | Open-market sale | −12,993 | $17.25 | $224,129 |
| Mar 16, 2026 | Odle Gregory A Officer (President of Scoliosis) | Open-market sale | −8,433 | $17.25 | $145,469 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.